Alpha Tau Medical stock trades at USD 15.30

Alpha Tau Medical Ltd. (ISIN IL0011833879) was quoted at USD 15.30 on September 23, 2026, down 1.29 percent on the Nasdaq. The market snapshot places the stock 28.84 percent below its 52-week high of USD 21.50 and 96.15 percent above its 52-week low of USD 7.80.

Nasdaq quote shows a wide range

The latest quoted price of USD 15.30 compares with a previous close of USD 15.50, an exact decline of USD 0.20 on September 23, 2026. That comparison puts the daily move below the stock's broader 52-week spread of USD 13.70, showing that the session change was modest relative to the yearly trading range.

Alpha Tau Medical develops cancer-treatment technology, while the available market profile classifies the company in the biotechnology industry. The Nasdaq quotation and the DRTS ticker identify the security used for the market figures in this article.

Operating figures remain the key test

For the current financial picture, investors need the company's most recent period-specific revenue, earnings and cash-flow figures alongside the share price. The available quote snapshot supplies the market signal for September 23, 2026, but does not provide a period-labelled operating comparison that can be stated as a current reported result.

The numerical contrast is therefore between the September 23 price and its yearly extremes: USD 15.30 is USD 6.20 below the high and USD 7.50 above the low. Those distances matter because the stock is closer to the middle of its annual range than to either boundary.

Price remains below the yearly high

Alpha Tau Medical stock stood at USD 15.30 on the Nasdaq as of September 23, 2026. The quoted daily change was negative 1.29 percent, with the share price remaining below the 52-week high of USD 21.50.

More news and analyses on Alpha Tau Medical stock